All Stories

  1. Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study

    Article • Journal of the American Society of Nephrology, September 2021, American Society of Nephrology

    An De Vriese

  2. Authors’ Reply

    Article • Journal of the American Society of Nephrology, August 2021, American Society of Nephrology

    An De Vriese

  3. Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial

    Article • Journal of the American Society of Nephrology, March 2021, American Society of Nephrology

    An De Vriese

  4. Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study

    Article • Journal of the American Society of Nephrology, November 2020, American Society of Nephrology

    An De Vriese

  5. Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study

    Article • Journal of the American Society of Nephrology, November 2019, American Society of Nephrology

    An De Vriese

  6. Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach

    Article • Journal of the American Society of Nephrology, January 2018, American Society of Nephrology

    An De Vriese, Dr Fernando Fervenza

  7. Should Statins Be Banned from Dialysis?

    Article • Journal of the American Society of Nephrology, May 2017, American Society of Nephrology

    An De Vriese